Compare CIB & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CIB | RVTY |
|---|---|---|
| Founded | 1945 | 1937 |
| Country | Colombia | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5B | 11.7B |
| IPO Year | 1995 | N/A |
| Metric | CIB | RVTY |
|---|---|---|
| Price | $75.15 | $112.96 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 14 |
| Target Price | $56.25 | ★ $113.46 |
| AVG Volume (30 Days) | 340.7K | ★ 1.2M |
| Earning Date | 02-19-2026 | 02-02-2026 |
| Dividend Yield | ★ 5.36% | 0.25% |
| EPS Growth | ★ 22.14 | N/A |
| EPS | 1.96 | ★ 1.99 |
| Revenue | ★ $6,289,868,892.00 | $2,813,367,000.00 |
| Revenue This Year | $33.27 | $5.30 |
| Revenue Next Year | $7.26 | $3.03 |
| P/E Ratio | ★ $10.34 | $57.71 |
| Revenue Growth | ★ 15.25 | 3.37 |
| 52 Week Low | $31.78 | $81.36 |
| 52 Week High | $75.75 | $128.29 |
| Indicator | CIB | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 83.50 | 69.34 |
| Support Level | $66.41 | $100.98 |
| Resistance Level | $68.60 | $115.78 |
| Average True Range (ATR) | 1.77 | 3.70 |
| MACD | 0.83 | 1.51 |
| Stochastic Oscillator | 94.55 | 86.02 |
Grupo Cibest SA formerly BanColombia SA is a financial services company. A conglomerate of financial institutions, BanColombia offers a wide range of product offerings and financial services, including loans to small and midsize enterprises and governments, leasing, factoring, and asset management. The company's operations are in Colombia, Panama, El Salvador, the United States of America, Puerto Rico, Bermuda, and Guatemala. The Bank has the following segments: Banking Colombia, Banking Panama, Banking El Salvador, Banking Guatemala, Trust, Investment Banking, Brokerage, International Banking and All other segments. The majority of revenue is generated from the Banking Colombia segment.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.